4,4,5,5-Tetramethyl-2-(3-phenylpropyl)-1,3,2-dioxaborolane, 98%, 25g

Methyl 5-deoxy-2,3-O-isopropylidene-beta-D-ribofuranoside, 95.0%, 250mg

ethyl 4-bromo-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate, 97.0%, 100mg

3-(2-Pyridyl)-D-alanine, >98%, 10g

1-(tert-Butoxycarbonyl)-4-piperidinemethanol>98.0%(GC)25g

5,7-DIHYDROX -4'-METHOXYISOFLAVONE, 95.0%, 5g

TRIFLUSAL, 98%, 1g

(3R)-3-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid, 97%, 100g

Kapillarpipetten mit Natriumheparinierung, 75 µl, 1000 Stück

S-Methyl 2-Furancarbothioate>98.0%(GC)25g

(Z)-N-(1-(4-Bromophenyl)-1-chloro-3-oxo-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide, 95%, 100mg

2-oxo-1H,2H,3H-pyrrolo[2,3-b]pyridine-4-carbonitrile, 95.0%, 250mg

(S)-Ethyl 2-((tert-butoxycarbonyl)amino)-4-iodobutanoate, 95%, 500mg